E25: Jeff Galvin, CEO of Addimmune on Finding a Cure for HIV

Jeff Galvin, CEO of Addimmune, sits down with David Weisburd to discuss cell and gene therapy, and how Addimmune is working on a functional solution for HIV. We’re proudly sponsored by Bidav Insurance Group, visit lux-str.com if you’re ready to level up your insurance plans. (0:00) Episode Preview (2:21) Jeff’s background (5:08) Teaching at MIT as a teenager (8:22) What is gene therapy? (11:53)Episode Sponsor: Bidav Insurance Group (12:39)Gene therapy success stories (16:11)What is HIV? (20:14)AGT103 and the quest for a functional HIV cure (23:22)AGT103’s Phase I results (29:43)How gene therapy could revolutionize pharmaceuticals (30:52)How to contact Addimmune